Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 10;59(12):2145.
doi: 10.3390/medicina59122145.

Atopic Dermatitis and the Risk of Infection in End-Stage Renal Disease

Affiliations

Atopic Dermatitis and the Risk of Infection in End-Stage Renal Disease

Rushan I Momin et al. Medicina (Kaunas). .

Abstract

Background and Objectives: Atopic dermatitis (AD), also known as eczema, is a common chronic inflammatory skin condition affecting 16.5 million adults in the United States. AD is characterized by an impaired epidermal barrier that can predispose individuals to infection. End-stage renal disease (ESRD) is also commonly complicated by infections due to chronic vascular access and immune-system dysfunction, possibly related to uremia. Multiple studies have reported that renal disease is a common comorbidity in adults with atopic dermatitis. The aim of this study was to determine whether AD is a risk factor for certain infections in patients with ESRD. Materials and Methods: Using the United States Renal Data System, a retrospective cohort analysis was conducted on adult ESRD patients initiating dialysis between 2004 and 2019 to investigate associations between infections and AD in this population. Results: Of 1,526,266 patients, 2290 were identified with AD (0.2%). Infectious outcomes of interest were bacteremia, septicemia, cellulitis, herpes zoster, and conjunctivitis. In all infectious outcomes except for conjunctivitis, patients with the infectious outcomes were more likely to carry a diagnosis of AD. After controlling for demographic and clinical covariates, AD was associated with an increased risk of cellulitis (adjusted relative risk (aRR) = 1.39, 95% confidence interval (CI) = 1.31-1.47) and herpes zoster (aRR = 1.67, CI = 1.44-1.94), but not with bacteremia (aRR = 0.96, CI = 0.89-1.05), septicemia (aRR = 1.02, CI = 0.98-1.08), or conjunctivitis (aRR = 0.97, CI = 0.740-1.34). Conclusions: Overall, after controlling for demographic and clinical covariates and adjusting for person-years-at-risk, AD was associated with an increased risk for some, but not all, infections within the population of patients with ESRD.

Keywords: atopic dermatitis; bacteremia; cellulitis; conjunctivitis; end-stage renal disease; herpes zoster; infection; septicemia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Forest plots for the final multivariable logistic regression models of atopic dermatitis in bacteremia (A), septicemia (B), cellulitis (C), herpes zoster (D), and conjunctivitis (E).

References

    1. Mohn C.H., Blix H.S., Halvorsen J.A., Nafstad P., Valberg M., Lagerløv P. Incidence Trends of Atopic Dermatitis in Infancy and Early Childhood in a Nationwide Prescription Registry Study in Norway. JAMA Netw. Open. 2018;1:e184145. doi: 10.1001/jamanetworkopen.2018.4145. - DOI - PMC - PubMed
    1. Chiesa Fuxench Z.C., Block J.K., Boguniewicz M., Boyle J., Fonacier L., Gelfand J.M., Grayson M.H., Margolis D.J., Mitchell L., Silverberg J.I., et al. Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population. J. Investig. Dermatol. 2019;139:583–590. doi: 10.1016/j.jid.2018.08.028. - DOI - PubMed
    1. Bylund S., Kobyletzki L.B., Svalstedt M., Svensson Å. Prevalence and Incidence of Atopic Dermatitis: A Systematic Review. Acta Derm. Venereol. 2020;100:adv00160. doi: 10.2340/00015555-3510. - DOI - PMC - PubMed
    1. Arkwright P.D., Koplin J.J. Impact of a Decade of Research Into Atopic Dermatitis. J. Allergy Clin. Immunol. Pract. 2023;11:63–71. doi: 10.1016/j.jaip.2022.09.021. - DOI - PubMed
    1. Leung D.Y.M., Boguniewicz M., Howell M.D., Nomura I., Hamid Q.A. New Insights into Atopic Dermatitis. J. Clin. Investig. 2004;113:651–657. doi: 10.1172/JCI21060. - DOI - PMC - PubMed